Formosa Laboratories, Inc. (4746) Stock Price & Analysis
4746 Stock Chart & Stats
- Day’s Range
- TWD 40.50 - TWD 45.10
- 52-Week Range
- TWD 40.50 - TWD 67.40
- Previous Close
- TWD 44.15
- Volume
- N/A
- Average Volume (3M)
- 518.37K
- Market Cap
- TWD 5.26B
- Enterprise Value
- TWD 8.92B
- Total Cash (Recent Filing)
- TWD 2.07B
- Total Debt (Recent Filing)
- TWD 3.21B
- Price to Earnings (P/E)
- 11.2
- Beta
- 0.39
- Next Earnings
- Nov 12, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Aug 24, 2026
- Dividend Yield
- 6.86%
4746 FAQ
What was Formosa Laboratories, Inc.’s price range in the past 12 months?
What is Formosa Laboratories, Inc.’s market cap?
When is Formosa Laboratories, Inc.’s upcoming earnings report date?
How were Formosa Laboratories, Inc.’s earnings last quarter?
Is Formosa Laboratories, Inc. overvalued?
Does Formosa Laboratories, Inc. pay dividends?
What is Formosa Laboratories, Inc.’s EPS estimate?
How many shares outstanding does Formosa Laboratories, Inc. have?
What happened to Formosa Laboratories, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Formosa Laboratories, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Formosa Laboratories, Inc.
Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and other areas; and injectables in the areas of IDA, MRI agents, oncology, and others. The company also provides contract development and manufacturing services, including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization; injectable manufacturing and secondary packaging, labeling, and serialization services; custom fermentation services; and peptide synthesis services. In addition, it offers antibody-drug conjugates services comprising antibody development and manufacture; peptide and polymer drug conjugation; linker-payload design, synthesis, and manufacturing; bio-conjugation and purification; cytotoxic liquid-filled and lyophilized product from pre-formulation studies to manufacture; and regulatory support. Further, the company is involved in chemical trading and investment activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan City, Taiwan.
- Sector
- General
- Industry
- Medical - Pharmaceuticals
- CEO
- Cheng Yue Cheng
- Employees
- 56
- Website
- www.formosalab.com
- Address
- No. 36 Hoping Street, Taoyuan City, TPE, 338002, TW
Formosa Laboratories, Inc. (4746) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |

